Bacterial Vaginosis: A Review of Pathophysiology, Epidemiology, Complications, Diagnosis, and Treatment
Abstract
Bacterial vaginosis (BV) is the most-common cause of abnormal vaginal discharge among women of reproductive age, though many are asymptomatic. It is caused by the replacement of normal vaginal Lactobacillus with Gram-negative and anaerobic organisms. BV has assumed increasing public health importance through associations with numerous adverse outcomes in both gravid and non-gravid women. Risk factors for BV include smoking, non-White race, prior BV, current other sexually transmitted diseases (STDs), inserting items in the vagina (e.g., sex, douching), and menses. Symptomatic BV has been associated with pelvic inflammatory disease (PID), miscarriage, premature rupture of membranes, chorioamnionitis, premature labor and delivery, postpartum endometritis, and post-hysterectomy vaginal cuff cellulitis. Anaerobic Gram-negative rods common to BV have also been independently associated with endometritis or PID, even in the absence of clinical BV. BV has also been independently associated with an increased risk of acquiring STDs, including acquiring and transmitting HIV. BV is not an STD, though recent sexual intercourse and multiple sex
partners are risk factors. BV causes a malodorous, white or gray vaginal discharge and is diagnosed through Amsel’s criteria. Treatment with metronidazole or clindamycin is important for symptom relief and to prevent adverse obstetric consequences, particularly among high-risk women who have had a previous preterm delivery or have a pre-pregnancy weight <50 kg.
References
Coudray MS, Madhivanan P. Bacterial vaginosis-A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol. 2020; 245:143-8. https://doi.org/10.1016/j.ejogrb.2019.12.035
Nelson DB, Macones G. Bacterial Vaginosis in Pregnancy: Current Findings and Future Directions. Epidemiol Rev. 2002; 24 (2):102-8. https://doi.org/10.2217/17455057.2.2.267
Haggerty CL, Hillier SL, Bass DC, Ness, RB, & PID Evaluation and Clinical Health (PEACH) Study Investigators. Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis. 2004; 39(7):990-5. https://doi.org/10.1086/423963
McKinnon LR, Achilles SL, Bradshaw CS, Burgener A, et al. The evolving facets of bacterial vaginosis: Implications for HIV transmission. AIDS Research and Human Retroviruses. 2019; 35(3):219-28. https://doi.org/10.1089/AID.2018.0304
Ranjit E, Raghubanshi BR, Maskey S, Parajuli P. Prevalence of Bacterial Vaginosis and Its Association with Risk Factors among Nonpregnant Women: A Hospital Based Study. Int J Microbiol. 2018; 5;2018:8349601. https://doi.org/10.1155/2018/8349601
Goldenberg RL, Klebanoff MA, Nugent R, et al. Bacterial colonization of the vagina during pregnancy in four ethnic groups. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1996; 174:1618-21. https://doi.org/10.1016/s0002-9378(96)70617-8
Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, et al. Deep sequencing of the vaginal microbiota of women with HIV. PLoS One. 2010; 5(8):e12078. https://doi.org/10.1371/journal.pone.0012078
Fettweis JM, Brooks JP, Serrano MG, Sheth NU, et al. The Vaginal Microbiome Consortium. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiology (Reading, England). 2014;160(Pt 10): 2272-82. https://doi.org/10.1099/mic.0.081034-0
Royce RA, Jackson TP, Thorp JM Jr, Hillier SL, et al. Race/ethnicity, vaginal flora patterns, and pH during pregnancy. Sex Transm Dis 1999; 26(2):96-102. https://doi.org/10.1097/00007435-199902000-00007
Koumans EH, Kendrick JS. Preventing Adverse Sequelae of Bacterial Vaginosis: A Public Health Program and Research Agenda. The CDC Bacterial Vaginosis Working Group. Sex Transm Dis 2001; 28(5): 292-7. https://doi.org/10.1097/00007435-200105000-00011
Bump RC, Buesching WJ. Bacterial vaginosis in virginal and sexually active adolescent females: Evidence against exclusive sexual transmission. Am J Obstet Gynecol. 1988; 158:935-9. https://doi.org/10.1016/0002-9378(88)90097-x
Madden T, Grentzer JM, Secura GM, Allsworth JE, et al. Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis. 2012;39(3):217-22. https://doi.org:10.1097/OLQ.0b013e31823e68fe
Brotman RM, Klebanoff MA, Nansel TR, Andrews WW, et al. A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis. Am J Epidemiol. 2008;168(2):188-96. https://doi.org/10.1093/aje/kwn103
Peebles K, Kiweewa FM, Palanee-Phillips T, Chappell C, et al. & MTN-020/ASPIRE study team. Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study. Clin Infect Dis. 2021;73(3):513-20. https://doi.org/10.1093/cid/ciaa703
Madden T, Grentzer JM, Secura GM, Allsworth JE, et al. Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study. Sex Transm Dis. 2012; 39(3):217-22. https://doi.org/10.1097/OLQ.0b013e31823e68fe.
Eschenbach DA, Patton DL, Hooton TM, Meier A.S, et al. Effects of Vaginal Intercourse with and without a Condom on Vaginal Flora and Vaginal Epithelium. The J Infect Dis. 2001; 183(6):913-8. 10.1086/319251
Schwebke JR, Richey CM, Weiss2 HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis. 1999 Nov;180(5):1632-6. https://doi.org/doi: 10.1086/315065.
Feng C, Li R, Shamim AA, Ullah MB, et al. High-resolution mapping of reproductive tract infections among women of childbearing age in Bangladesh: a spatial-temporal analysis of the demographic and health survey. BMC Public Health. 2021; 21(1):342. https://doi.org/10.1186/s12889-021-10360-4
Thoma ME, Klebanoff MA, Rovner AJ, Nansel TR, et al. Bacterial vaginosis is associated with variation in dietary indices. J Nutr. 2011; 141(9):1698-704. https://doi.org/10.3945/jn.111.140541
Neggers YH, Nansel TR, Andrews WW, Schwebke JR, et al. Dietary intake of selected nutrients affects bacterial vaginosis in women. J Nutr. 2007;137(9):2128-33. https://doi.org/10.1093/jn/137.9.2128.
Christian P, West K, S. Khatry, Katz J, et al. Night blindness of pregnancy in rural Nepal - nutritional and health risks. Int. J Epidemiol. 1998; 27(2):231-7. https://doi.org/10.1093/ije/27.2.231
Christian P, Labrique AB, Ali H, Richman MJ, et al. Maternal vitamin A and β-carotene supplementation and risk of bacterial vaginosis: a randomized controlled trial in rural Bangladesh, Am J Clin Nutr. 2011; 94(6):1643-9. https://doi.org/10.3945/ajcn.111.019059
Turovskiy Y, Cheryian T, Algburi A, Wirawan RE, et al. Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester. Infect Dis Obstet Gynecol. 2012; 284762. https://doi.org/10.1155/2012/284762
Hillier SL, Lau RJ. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clin Infect Dis. 1997;25(Suppl 2): S123-6.
Chee WJ, Chew SY, Than LT. Vaginal microbiota and the potential of lactobacillus derivatives in maintaining vaginal health. Microb Cell Fact. 2020;19(1):203. https://doi.org/10.1186/s12934-020-01464-4
Hawes SE, Hillier SL, Benedetti J, Stevens CE, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infection. J Infect Dis. 1996; 174(5):1058-63. https://doi.org/10.1093/infdis/174.5.1058
Hainer BL, Gibson MV. Vaginitis. Am Fam Physician. 2011; 83(7):807-15.
Amsel R, Totten PA, Spiegal CA, et al. Nonspecific vaginitis: diagnostic criteria and microbil and epidemiologic associations. Am J Med. 1983; 74(1):14-22. https://doi.org/10.1016/0002-9343(83)91112-9
Krohn MA, Hillier, SL, Eschembach DA. Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol. 1989; 27(6):1266-71. https://doi.org/10.1128/jcm.27.6.1266-1271.1989
Schadig VJ, Davie KD, Shafer SK, et al. The cytologist and bacterioses of the vaginal-ectocervical area. Acta Cytol. 1989; 33(3):287-97.
Schwebke JR. Role of Vaginal Flora As a Barrier to HIV Acquisition. Curr Infect Dis Rep. 2001; 3(2):152-5. https://doi.org/10.1007/s11908-996-0040-6
Hashemi FB, Ghassemi M, Roebuck KA, Speat GT. Activation of human immunodeficiency type 1 expression by Gardnerella vaginalis. J Infect Dis. 1999; 179(4): 924-30. https://doi.org/10.1086/314674
Carey JC, Klebanoff MA, Hauth JC. Hillier SL, et al. Metronidazole to prevent preterm delivery in pregnany women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 2000; 342(8):534-40. https://doi.org/10.1056/NEJM200002243420802
Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod. 2001; 16(9):1809-13. https://doi.org/10.1093/humrep/16.9.1809
Platz-Christensen JJ, Pernevi P, Hagmar B, et al. A longitudinal follow-up of bacterial vaginosis during pregnancy. Acta Obstet Gynaecol Scand. 1993; 72(2):99-102. https://doi.org/10.3109/00016349309023420
McGRegor JA, French JI, Parker R, Draper D, et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173(1):157-67. https://doi.org/10.1016/0002-9378(95)90184-1
French JI, McGregor JA, Draper D, Parker R, et al. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: risk for preterm delivery and benefit of treatment. Obstet Gynecol. 1999; 93(5 Part 1):715-24. https://doi.org/10.1016/s0029-7844(98)00557-2
Hillier SL, Nugent HP, Eschenbach DA, Krohn MA, et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995; 333(26):1737-42. https://doi.org/10.1056/NEJM199512283332604
Guerra, B., Ghi, T., Quarta, S., Morselli-Labate, A. M., Lazzarotto, T., Pilu, G., & Rizzo, N. (2006). Pregnancy outcome after early detection of bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol. 2006;128(1-2):40-5. https://doi.org/10.1016/j.ejogrb.2005.12.024
Hitti J, Hillier SL, Agnew KJ, et al. Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol. 2001; 97(2):211-9. https://doi.org/10.1016/s0029-7844(00)01146-7
McGregor JA, French JI, Seo K. Premature rupture of membranes and bacterial vaginosis. Am J Obstet Gynecol. 1993; 169(2 Pt 2):463-6. https://doi.org/10.1016/0002-9378(93)90342-g
Donders GG, Van Bulck B, Caudron J, et al. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol. 2000; 183(2):431-7. https://doi.org/10.1067/mob.2000.105738
Larsson PG, Platz-Christensen JJ, Thejls H, Forsum U, et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized stud. Am J Obstet Gynecol. 1992; 166(1 Pt 1):100-3. https://doi.org/10.1016/0002-9378(92)91838-2
Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, et al. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med. 1995; 333(26):1732-6. https://doi.org/10.1056/NEJM199512283332603
Vermeulen GM, Bruinse HW. Prophylactic administration of clindamycin 2% vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk: a randomized placebo-controlled double-blind trial. Br J Obstet Gynaecol. 1999; 106(7):652-7. https://doi.org/10.1111/j.1471-0528.1999.tb08363.x
Lewis AL, Laurent LC. USPSTF 2020 Recommendations on Screening for Asymptomatic Bacterial Vaginosis in Pregnancy. JAMA. 2020;323(13):1253–5. https://doi.org/10.1001/jama.2019.22311
Workowski KA, Bachmann LH, Chan PA, Johnston CM, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021. 23;70(4):1-187. https://doi.org/10.15585/mmwr.rr7004a1
Livengood CH 3rd, McGregor JA, Soper DE, Newton E, et al. Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment. Am J Obstet Gynecol. 1994;170(3):759-64. https://doi.org/10.1016/s0002-9378(94)70278-0
Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: A prospective, double-blind clinical trial. South Med J. 1992; 85(11):1077-80. https://doi.org/10.1097/00007611-199211000-00006
McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream Am J Obstet Gynecol. 1994; 170(4):1048-59. https://doi.org/ 10.1016/s0002-9378(94)70098-2
Jayaram PM, Mohan MK, Konje J. Bacterial vaginosis in pregnancy - a storm in the cup of tea. Eur J Obstet Gynecol Reprod Biol. 2020; 253:220-4. https://doi.org/10.1016/j.ejogrb.2020.08.009
Hay PE, Lamont RF, Taylor-Robinson D, Morgan DJ. Abnormal bacterial colonization of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 1994; 308(6924):295-8. https://doi.org/ 10.1136/bmj.308.6924.295
Schwebke JR, Weiss HL. Interrelationships of Bacterial Vaginosis and Cervical Inflammation. Sex Transm Dis. 2002;29(1):59-64. https://doi.org/10.1097/00007435-200201000-00010
Byrne MA, Turner MJ, Griffiths M, et al. Evidence that patients presenting with dyskaryotic cervical smears should be screened for genital-tract infections other than human papillomavirus infection. Eur J Obstet Gynecol Reprod Biol. 1991; 41(2):129-33. https://doi.org/10.1016/0028-2243(91)90090-8
Falagas M, Betsi GI, Athanasiou S. Probiotics for the treatment of women with bacterial vaginosis. Clin Microbiol Infect. 2007; 13(7):657-4. https://doi.org/10.1111/j.1469-0691.2007.01688.x.
Holley R, Richter H, Edward V, Pair L. A Randomized, Double-Blind Clinical Trial of Vaginal Acidification versus Placebo for the Treatment of Symptomatic Bacterial Vaginosis. Sex Transm Dis. 2004; 31(4):236-8. https://doi.org/10.1097/01.olq.0000118423.20985.e7
Moi H, Erkkola R, Jerve F, Nelleman G. Should male consorts of women with bacterial vaginosis be treated? Genitourin Med. 1989; 65(4):263-8. https://doi.org/10.1136/sti.65.4.263
Bradshaw CS, Morton AN, Hocking J, Garland SM, et al. High Recurrence Rates of Bacterial Vaginosis over the Course of 12 Months after Oral Metronidazole Therapy and Factors Associated with Recurrence. J Infect Dis. 2006;193(11):1478-86. https://doi.org/10.1086/503780
Copyright (c) 2023 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/
